Clinical Trial

SCREENING AFTER STROKE - ATRIAL FIBRILLATION

Study acronym: SAS-AF
Recruiting
View on ClinicalTrials.gov →
Summary
As much as 20-30% of all strokes are attributed to atrial fibrillation (AF), making the detection of AF highly important, as AF-related strokes are largely preventable with optimal treatment. Therefore, most guidelines recommend screening patients for AF after a stroke, although the optimal timing and choice of monitoring device for screening remain undefined. Our aim is to investigate whether AF screening as early as possible after stroke symptom onset provides a higher detection rate compared to screening after discharge. Additionally, we aim to determine if a 3-lead ECG device provides a higher detection rate compared to a 1-lead patch recorder.
Trial Details
NCT Number NCT06675383
Lead Sponsor Vestre Viken Hospital Trust
Conditions Atrial Fibrillation (AF)
Enrollment 410 participants
Start Date 2024-11-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2033-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-05